Gennao Bio
Company

Gennao Bio

Biotechnology 311 Pennington Rocky Hill Rd 9 employees
Employees
9
Contacts
1
Emails
1

Gennao Bio Overview

Headquarters
311 Pennington Rocky Hill Rd
Website
www.gennao.com
Industry
Biotechnology
Employees
9
Founded
2020
Funding
1.0M
Keywords

About Gennao Bio

Gennao Bio is a privately held genetic medicines company developing first-in-class targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology. GMAB is an adaptive technology that uses a novel, cell-penetrating antibody to non-covalently bind to and systemically deliver therapeutic levels of a wide variety of nucleic acid payloads to select cells, including mRNA, synthetic RNA, DNA, si-RNA, ASOs and gene-editing molecules. This non-viral delivery platform is differentiated from traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and employs well-established manufacturing processes. Gennao Bio is developing this delivery system with an initial focus on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases.

Gennao Bio Contact Details

People in AeroLeads
4
With contact data
1
Email contacts
1
25.0% coverage

Gennao Bio Org Chart

Sample employees and titles
Name Title Contact
Jacob Lundt
View
Nithya Sivaram Sr. Scientist, Pharmacology - Phd
Email
Zahra Erami Sr. Scientist
View
Ketan Patil Team Lead, Molecular and Cell Biology
View

Employees by Management Level

Senior / Lead 3 profiles

Gennao Bio Tech Stack

Data / AI 2 profiles

Compare Similar Companies to Gennao Bio